[Neurogenic ventricular dysfunction and aneurysmatic subarachnoid hemorrhage].
Ruiz
A
A
Fábregas
N
N
Sala
X
X
García
C
C
D017542:Aneurysm, Ruptured / Q000150:complications*; D016470:Bacteremia / Q000150:complications; D015415:Biomarkers; D001991:Bronchitis / Q000150:complications; D006328:Cardiac Catheterization; D003128:Coma / Q000209:etiology; D003327:Coronary Disease / Q000175:diagnosis; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D006801:Humans; D007022:Hypotension / Q000188:drug therapy / Q000209:etiology; D002532:Intracranial Aneurysm / Q000150:complications*; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D017682:Myocardial Stunning / Q000097:blood / Q000175:diagnosis / Q000209:etiology*; D009638:Norepinephrine / Q000627:therapeutic use; D011379:Prognosis; D012008:Recurrence; D013345:Subarachnoid Hemorrhage / Q000150:complications*; D014136:Tracheitis / Q000150:complications; D019210:Troponin I / Q000097:blood*
D015415:Biomarkers; D019210:Troponin I; D009638:Norepinephrine